Business
Which biotech’s shares have hit a 12-month high on good news from the FDA?
Image source: Getty Images
Shareholders in Neuren Pharmaceuticals Ltd (ASX: NEU) are rejoicing after one of the company’s drugs, which shows promise in treating a rare genetic disorder, received fast-track designation from the US Food & Drug Administration (FDA).
Neuren told the ASX in a…
Continue Reading
-
Noosa News14 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News23 hours agoE-Scooter accident | Noosa Today
-
General22 hours agoOutback Farm stars finish first barley harvest at Central Australian farm
-
Noosa News14 hours agoNon-compliance, human error led to $2m Noosa Council fraud